Home > Income Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Revenue

    Back to Income Statement
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Net Sales ₹365 Cr₹333 Cr₹301 Cr₹278 Cr₹138 Cr

What is the latest Revenue of NATH BIOGENES (INDIA) ?

The latest Revenue ratio of NATH BIOGENES (INDIA) is ₹365 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹365 Cr
Mar2024₹333 Cr
Mar2023₹301 Cr
Mar2022₹278 Cr
Mar2013₹138 Cr

How is Revenue of NATH BIOGENES (INDIA) Trending?

Years Revenue % Change
Mar2025 ₹365 Cr
9.71
Mar2024 ₹333 Cr
10.37
Mar2023 ₹301 Cr
8.26
Mar2022 ₹278 Cr
102.15
Mar2013 ₹138 Cr -

Compare Revenue of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹273.6 Cr -4% -4.3% -9.5% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹11,316.7 Cr -4.3% -7.7% -2.2% Stock Analytics
KAVERI SEED COMPANY ₹3,856.1 Cr -2.8% -19.9% -27% Stock Analytics
VENKYS (INDIA) ₹1,809.5 Cr -4.7% -18.6% -19.4% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹889.8 Cr -5.6% -7% -37.8% Stock Analytics
INDO US BIOTECH ₹226.3 Cr -20.5% -9.8% -34.6% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-4%

-4.3%

-9.5%

SENSEX

-4.1%

-5.8%

5.8%


You may also like the below Video Courses